Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Linda Monaco-Shawver(Children's Hospital of Philadelphia), Jordan S. Orange(Children's Hospital of Philadelphia), Steven D. Douglas(Purdue University West Lafayette), Changjiang Guo(Henan Medical University), Satya M. Gunnam(Children's Hospital of Philadelphia), Pinaki P. Banerjee(The University of Texas MD Anderson Cancer Center), Lynnae Schwartz(Children's Hospital of Philadelphia), Laurie E. Kilpatrick(Temple University), Jianping Lai(Southwest University of Science and Technology), Florin Tuluc(Children's Hospital of Philadelphia)
Cited by 37
Related Papers
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390